Evidence map›Paper›PMID 40628402›Full record

ReviewMolecular human reproduction2025

WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent models.

M Louise Hull, Raul Gomez, Warren B Nothnick, Ruth Gruemmer, Katherine A Burns, Mohammed Zahied Johan, Isabella R Land, Stacey A Missmer, Lone Hummelshoj, Erin Greaves and 2 more

Erratum issuedAbstract readReview
In one paragraph

Review in Molecular human reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

M Louise HullThe Robinson Research Institute, University of Adelaide, Adelaide, Australia.
Raul GomezResearch Unit on Women's Health-INCLIVA, Institute of Health Research, Valencia, Spain.
Warren B NothnickDepartment of Cell Biology and Physiology, Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, KS, USA.ORCID 0000-0002-2349-1880
Ruth GruemmerDepartment of Anatomy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-9405-7213
Katherine A BurnsDepartment of Environmental and Public Health Servies, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Mohammed Zahied JohanCentre for Cancer Biology, University of Adelaide, Adelaide, Australia.
Isabella R LandDepartment of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA.
Stacey A MissmerDepartment of Obstetrics and Gynaecology, University of Michigan, Ann Arbour, MI, USA.
Lone HummelshojWorld Endometriosis Research Foundation, London, UK.
Erin GreavesWorld Endometriosis Research Foundation, London, UK.ORCID 0000-0001-9165-5851
Kaylon L Bruner-TranDepartment of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA.
EPHect Experimental Models Working Group

Funding

World Endometriosis Research Foundation
6 · The paper itself

Abstract

Endometriosis, defined as the growth of endometrial-like tissues outside the uterus, is a common disease among women. Numerous in vivo rodent models of endometriosis have been developed to explore multiple aspects of this poorly understood disease. Heterologous models utilize human endometrial tissues engrafted into immunocompromized mice, while homologous models engraft rodent endometrium into immunocompetent mice or rats. Heterologous models of endometriosis more closely replicate the human disease; however, the murine humoral immune response must be suppressed to prevent rejection of the xenograft tissue. Although the innate immune system remains intact, suppression of the humoral response leads to a markedly different local and systemic immune environments compared to humans. Despite this limitation, experiments using heterologous models have contributed significantly to our understanding of endometriosis establishment and progression, the pre-clinical effectiveness of various therapeutic strategies, and genetically modifiable host factors that contribute to disease. Unfortunately, a lack of harmonization of the models used by different laboratories has impeded the reproducibility and comparability of results between groups. Therefore, the World Endometriosis Research Foundation (WERF) formed an international working group of experts in heterologous models of endometriosis to develop guidelines and protocols that could contribute to unifying experimental approaches across laboratories. Nine critical variables were identified: (i) mouse strain; (ii) human tissue type; (iii) hormonal status of the human tissue donor; (iv) human tissue preparation; (v) method and location of tissue placement; (vi) hormonal status of the recipient animal; (vii) whether or not mice were engrafted with human immune cells; (viii) endpoint assessments; and (ix) number and type of replicates. Herein, we outline important considerations for each major variable and make recommendations for unification of approaches. Widespread adoption of harmonized protocols and implementation of standardized documentation and reporting should further improve the reproducibility and translation of experimental findings both within and between laboratories.

Indexed as

Biological Specimen BanksDisease Models, AnimalEndometriosisAnimalsEndometriumFemaleHumansMiceRatscollaborationendometriosisexperimental modelsheterologousresearchrodents

Identifiers

PMID40628402
PMCPMC12237513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.